Ripple Therapeutics Corp.
$50,000.00 CAD
≈ 8 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- November 16, 2021 – November 30, 2022
- Reference
- nrc-cnrc:172-2021-2022-Q3-982618
Published purpose
The goal of this project is to engineer unique drug delivery systems using prodrug materials that will improve upon current controlled drug release technologies for the treatment of opioid use disorder. This will involve evaluating chemically modifying an API so that it can be processed into a sustained release injectable form that exhibits surface erosion based drug release without the use of polymers or excipients. This work will be pursued for APIs in the opioid antagonist drug class
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions